SCHEMBL7704022

SCHEMBL7704022

CC(C)(C)Oc1cc(NC(=O)O)c([N+](=O)[O-])cc1I

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.41
RAB9A P51151 4/20 0.41
ALDH1A1 P00352 4/20 0.41
MAPK1 P28482 2/20 0.41
HTT P42858 2/20 0.41
GLA P06280 1/20 0.41
CASP3 P42574 1/20 0.41
SENP8 Q96LD8 1/20 0.41
SENP7 Q9BQF6 1/20 0.41
SENP6 Q9GZR1 1/20 0.41
MAPT P10636 3/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
RECQL P46063 1/20 0.38
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
CYP1A2 P05177 2/20 0.37
CYP2C19 P33261 2/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7145419 0.87 MMP1 (0.39) NPC1RAB9AALDH1A1MAPK1HTT
SCHEMBL7700537 0.85 MAPT (0.46) NPC1RAB9AALDH1A1MAPK1MAPT
SCHEMBL7704609 0.83 KDM4E (0.43) NPC1RAB9AALDH1A1MAPK1HTT
SCHEMBL7698657 0.79 MAPT (0.49) NPC1RAB9AALDH1A1MAPK1HTT
SCHEMBL6608481 0.77 CXCR2 (0.43) NPC1RAB9AALDH1A1HTTMAPT
SCHEMBL7141612 0.77 PKM (0.43) ALDH1A1HTTMAPTSMN1; SMN2MEN1
SCHEMBL1694595 0.76 MAPT (0.49) NPC1RAB9AALDH1A1MAPK1HTT
SCHEMBL27498855 0.75 MEN1 (0.34) ALDH1A1HTTMAPTMEN1KMT2A
SCHEMBL7698485 0.75 MEN1 (0.40) NPC1RAB9AALDH1A1MAPK1HTT
SCHEMBL7698574 0.74 NPC1 (0.49) NPC1RAB9AALDH1A1MAPK1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1224174-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2002-07-24 EP disclosed
WO-2001029011-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2001-04-26 WO disclosed